pathophysiological mechanism
[대역어] None
[용어속성] Action
[용어속성] Action
Post-COVID-19 syndrome, low-grade inflammation and inflammatory markers: a cross-sectional study
Post-COVID-19 증후군, 저등급 염증 및 염증 표지자: 단면 연구
Article
[키워드] acute COVID-19
acute phase
affected
age
Ageusia
analysed
analysis
Anosmia
association
available data
best
Biomarker
Biomarkers
BMI
C-reactive protein
collected
Community
community setting
Comorbidities
correlation
COVID-19
COVID-19 case
cross-sectional
cross-sectional study
CRP
D-dimer level
D-dimer levels
defined
develop
distributions
Dyspnea
Elevation
epidemiological data
fatigue
ferritin
fibrinogen
Fibrinogen levels
Frequency
highest
identify
increased risk
Infection
Inflammatory
inflammatory markers
Laboratory
Laboratory test
Lactate
lactate dehydrogenase
low-grade inflammation
lymphocyte
lymphocyte counts
marker
men
Mild
mild COVID-19.
multivariable analysis
multivariate
multivariate analyses
myalgia
neutrophil
neutrophil count
neutrophil counts
neutrophil/lymphocyte ratio
NLR
pathophysiological mechanism
performed
post-COVID syndrome
prevalent
reported symptom
selected
serum C-reactive protein
Sex
Sex difference
Signs and symptoms
smoking
subject
Symptom
Symptoms
syndrome
the median
variable
with COVID-19
woman
women
[DOI] 10.1080/03007995.2022.2042991 PMC 바로가기 [Article Type] Article
[DOI] 10.1080/03007995.2022.2042991 PMC 바로가기 [Article Type] Article
A novel case of lupus nephritis and mixed connective tissue disorder in a COVID-19 patient
Case report
[키워드] acute renal injury
addition
addressed
Administered
Anemia
antinuclear antibody
Autoimmune
Autoimmune disease
autoimmune disorder
Autoimmune disorders
characterized
complete blood count
connective tissue
COVID-19
COVID-19 infection
COVID-19 patient
creatinine
Critical
Cyclophosphamide
diagnosed
diagnostic
discharged
disease
disorder
edema
elevated
Factor
female
hepatosplenomegaly
Hydroxychloroquine
Inflammatory marker
intravenous
lower dose
Lupus
lupus nephritis
medication
morbidity
nodules
nuclear
oral steroid
organ dysfunction
pathophysiological mechanism
Patient
PCR-confirmed COVID-19
Pneumonia
polymyositis
positive
Prevent
Protein
reported
respiratory infection
Rheumatoid
ribonucleoprotein
Scleroderma
SLE
steroid
striae
symptomatic
systemic
treat
Treatment
[DOI] 10.1016/j.amsu.2022.103653 [Article Type] Case report
[DOI] 10.1016/j.amsu.2022.103653 [Article Type] Case report
Post-COVID-19 Fatigue and SARS-CoV-2 Specific Humoral and T-Cell Responses in Male and Female Outpatients
남성 및 여성 외래 환자의 코로나19 이후 피로 및 SARS-CoV-2 특정 체액 및 T-세포 반응
Article
[키워드] acute COVID-19
acute infection
Analysis
assessment
both sexes
Clinical characteristics
conducted
Course
COVID-19
development
disease
ELISA
ELISPOT
enzyme-linked immunosorbent
evaluate
Ex vivo
examined
fatigue
female
Germany
humoral
IFN-γ
IFNγ
IgG antibody
IL-2
individual
Inflammation
interferon-γ
Level
male
median time
men
mild infection
not differ
Outpatient
outpatients
outpatients.
participant
pathophysiological mechanism
producing
response
SARS-CoV-2
SARS-CoV-2-specific T-cell response
scale
Serum level
significantly
significantly lower
Specific
suffered
T-cell
T-cell Response
T-cells
treated
university
were measured
women
[DOI] 10.3389/fimmu.2022.902140 PMC 바로가기 [Article Type] Article
[DOI] 10.3389/fimmu.2022.902140 PMC 바로가기 [Article Type] Article
Neurologic manifestations in children with COVID-19 from a tertiary center in Turkey and literature review
Research article
Published on
Journal: European journal of paediatric neurology : EJPN :
[Category] COVID19(2023년), SARS, 변종,
Journal: European journal of paediatric neurology : EJPN :
[Category] COVID19(2023년), SARS, 변종,
[키워드] acute respiratory syndrome
analyzed
article
association
caused
Central nervous system
children
children with COVID-19
clinical
clinical presentation
coronavirus
coronavirus disease
COVID-19
described
Encephalopathy
event
global pandemic
Hospitalization
increasingly
Inflammatory
literature review
manifestation
MIS-C
neurologic
neurological
neurological manifestation
Neurological symptom
NEUROLOGY
pathophysiological mechanism
Patient
Pediatric patient
performed
ranged
required
Respiratory disease
Result
SARS-CoV-2
SARS-COV-2 infection
Seizure
Seizures
syndrome
the patient
Turkey
university
with COVID-19
[DOI] 10.1016/j.ejpn.2022.02.003 [Article Type] Research article
[DOI] 10.1016/j.ejpn.2022.02.003 [Article Type] Research article
Diabetes and COVID-19; A Bidirectional Interplay
Endocrinology
[키워드] ACE2
acute respiratory syndrome
addition
antidiabetic medication
bidirectional
binding site
Clinical data
Complication
coronavirus
coronavirus disease
COVID-19
Critical care
diabete
diabetes
dysregulation
Effect
endothelial (dys)function
Endothelium
enzyme
Express
Glucose
Health
higher risk
homeostasis
Hypothesis
individual
infected with SARS-CoV-2
metabolism
new onset diabetes
pancrea
pathophysiological mechanism
patients
patients with diabete
Prevent
receptors
recovering patients
SARS-CoV-2
Support
Treatment
virus
[DOI] 10.3389/fendo.2022.780663 PMC 바로가기 [Article Type] Endocrinology
[DOI] 10.3389/fendo.2022.780663 PMC 바로가기 [Article Type] Endocrinology
Death after the Administration of COVID-19 Vaccines Approved by EMA: Has a Causal Relationship Been Demonstrated?
Review
[키워드] Administered
benefit
carried
Causal
causal link
cause
clinical trial
COVID-19
COVID-19 vaccination
COVID-19 vaccine
death
dose
eight
events
excluded
highlight
immune
literature review
Myocardial infarction
myocarditis
pathophysiological mechanism
Post-mortem
relationship
reported
risk
SARS-CoV-2
Scientific community
Side effects
Spread
Surveillance
the vaccine
thrombotic
vaccination
Vaccine
[DOI] 10.3390/vaccines10020308 PMC 바로가기 [Article Type] Review
[DOI] 10.3390/vaccines10020308 PMC 바로가기 [Article Type] Review
Frequency and Associations of Adverse Reactions of COVID-19 Vaccines Reported to Pharmacovigilance Systems in the European Union and the United States
Public Health
[키워드] Adverse
Adverse reaction
age
allergic
Allergic reactions
analysed
arrhythmia
AstraZeneca
calculated
Cardiovascular events
categories
category
chimeric virus vaccines
Coagulation
common
COVID-19
COVID-19 vaccination
COVID-19 vaccine
COVID-19 vaccines
death
drug
estimate
European
Frequency
higher risk
hospitalisations
individual
Influenza
influenza vaccine
influenza vaccines
janssen
life-threatening
limitation
messenger RNA (mRNA)
Moderna
mRNA vaccines
neurological
occurred
ocular
Older
Pain
pathophysiological mechanism
Pfizer-BioNTech
pharmacovigilancce
pharmacovigilance
Population
populations
provide
reaction
Reactions
reported
Reporting
Research
Result
risk
SARS-CoV-2
serious adverse reaction
sexual organ
Suspected
System
the United State
thrombosis
union
vaccination
Vaccine
[DOI] 10.3389/fpubh.2021.756633 PMC 바로가기 [Article Type] Public Health
[DOI] 10.3389/fpubh.2021.756633 PMC 바로가기 [Article Type] Public Health
Pathological sequelae of long-haul COVID
장거리 코로나의 병적 후유증
Review
[키워드] Autoimmunity
clinical
Concentration
convalescent individuals
coronavirus disease
Coronavirus disease 2019
COVID
COVID-19
diagnostic
Diagnostic strategies
disorder
Dyspnea
fatigue
heterogeneous
include
increasingly
Inflammation
involved
malaise
Manifestations
memory
Neuropsychiatric
organ system
organ-specific
pathological
pathophysiological mechanism
present
reservoirs
review
successive wave
successive waves
syndrome
variety
Viral variants
[DOI] 10.1038/s41590-021-01104-y PMC 바로가기 [Article Type] Review
[DOI] 10.1038/s41590-021-01104-y PMC 바로가기 [Article Type] Review
Human genetics of SARS-CoV-2 infection and critical COVID-19
Review
Published on
Journal: Clinical microbiology and infection : the official
[Category] COVID19(2023년), SARS, 유전자 메커니즘, 진단, 치료제,
Journal: Clinical microbiology and infection : the official
[Category] COVID19(2023년), SARS, 유전자 메커니즘, 진단, 치료제,
[키워드] antiviral immune response
antiviral response
autoantibody
Autoimmune
clinical implication
Complication
content
Course
COVID-19
Critical
Diagnosis
disease
disease course
disease manifestation
Genetic
genetic loci
genetics
Genome-wide association studies
Human
humans
hypothese
IFN
immune
Immunity
IMPROVE
Inborn error of immunity
individual
Infection
Inflammatory
Innate immunity
interferon
knowledge
lethal disease
men
MIS-C
Neutralizing
objective
outcome
outlined
Pandemics
pathophysiological mechanism
pathophysiology
pathway
Patient
patients with SARS-CoV-2
Pneumonia
Prophylaxis
proportion
provide
provided
reduce
response
retrospective
SARS-CoV-2
SARS-COV-2 infection
severe SARS-CoV-2
Signaling
Source
susceptibility
susceptible individual
the SARS-CoV-2
Treatment
Type I IFN
virus
whole-exome sequencing
[DOI] 10.1016/j.cmi.2022.02.022 [Article Type] Review
[DOI] 10.1016/j.cmi.2022.02.022 [Article Type] Review